falciparum, which is targeted by the vaccine, is believed to be the most common on the continent and the “most lethal malaria parasite globally.” “Malaria has haunted Sub-Saharan Africa for generations, causing great personal misery,” said Matshidiso Moeti, WHO regional director for Africa, in a statement. Malaria is the “leading cause” of illness and death in children in Sub-Saharan Africa, according to the organization, with over 260,000 African children under the age of five dying each year. The vaccine is “possible to give,” has a “good safety profile,” has no detrimental effects on other childhood immunizations, is cost-effective, and reduces severe malaria by 30%, according to the findings of the pilot trial.ĭespite progress in the fight against the illness, approximately 200 million cases and 400,000 fatalities are reported each year worldwide, with Africa bearing the “highest” burden. “Today, the RTS,S malaria vaccine, which has been in development for more than 30 years, alters the trajectory of public health history.” The decision to suggest the vaccine, developed by GlaxoSmithKline (GSK) and marketed as “Mosquirix,” is based on the findings of a malaria vaccine pilot study that has been running in Kenya, Ghana, and Malawi since 2019. “Today, WHO recommends widespread use of the world’s first malaria vaccine,” said Tedros Adhanom Ghebreyesus, WHO Director-General.
#Parasite subs free#
All of our services are free for everyone.
#Parasite subs series#
falciparum malaria transmission is moderate to high. IRTV24 is a Media for everyone who like watching movies, TV Series and other videos online with good speed. The WHO has now recommended the “widespread use” of the world’s first malaria vaccine among children in Sub-Saharan Africa, as well as other areas where P.
0 kommentar(er)
